Profund Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.82M Sell
9,591
-4,499
-32% -$4.56M 0.32% 45
2025
Q4
$15.1M Buy
14,090
+2,577
+22% +$2.46M 0.46% 33
2025
Q3
$8.78M Sell
11,513
-1,245
-10% -$926K 0.29% 54
2025
Q2
$9.95M Buy
12,758
+1,024
+9% +$796K 0.36% 47
2025
Q1
$9.69M Sell
11,734
-983
-8% -$818K 0.42% 43
2024
Q4
$9.82M Buy
12,717
+219
+2% +$181K 0.36% 44
2024
Q3
$11.1M Sell
12,498
-940
-7% -$845K 0.42% 41
2024
Q2
$12.2M Sell
13,438
-325
-2% -$260K 0.45% 36
2024
Q1
$10.7M Buy
13,763
+760
+6% +$541K 0.42% 37
2023
Q4
$7.58M Sell
13,003
-366
-3% -$214K 0.33% 53
2023
Q3
$7.18M Sell
13,369
-540
-4% -$278K 0.4% 42
2023
Q2
$6.52M Sell
13,909
-195
-1% -$81.8K 0.35% 43
2023
Q1
$4.84M Sell
14,104
-6,589
-32% -$2.22M 0.3% 53
2022
Q4
$7.57M Buy
20,693
+5,812
+39% +$2.06M 0.49% 37
2022
Q3
$4.81M Sell
14,881
-960
-6% -$304K 0.35% 50
2022
Q2
$5.14M Sell
15,841
-2,440
-13% -$732K 0.33% 52
2022
Q1
$5.24M Sell
18,281
-3,608
-16% -$929K 0.22% 75
2021
Q4
$6.05M Buy
21,889
+2,262
+12% +$573K 0.2% 81
2021
Q3
$4.54M Sell
19,627
-217
-1% -$53.6K 0.15% 113
2021
Q2
$4.55M Buy
19,844
+105
+0.5% +$21.1K 0.15% 110
2021
Q1
$3.69M Sell
19,739
-3,275
-14% -$641K 0.14% 123
2020
Q4
$3.89M Buy
23,014
+201
+0.9% +$30K 0.17% 106
2020
Q3
$3.38M Sell
22,813
-5,769
-20% -$893K 0.17% 101
2020
Q2
$4.69M Buy
28,582
+6,699
+31% +$1.03M 0.26% 70
2020
Q1
$3.04M Sell
21,883
-8,089
-27% -$1.11M 0.23% 84
2019
Q4
$3.94M Buy
29,972
+2,301
+8% +$267K 0.17% 108
2019
Q3
$3.09M Sell
27,671
-4,208
-13% -$468K 0.16% 118
2019
Q2
$3.53M Sell
31,879
-5,748
-15% -$677K 0.17% 113
2019
Q1
$4.88M Sell
37,627
-6,599
-15% -$802K 0.23% 78
2018
Q4
$5.12M Sell
44,226
-11,194
-20% -$1.25M 0.32% 51
2018
Q3
$5.95M Buy
55,420
+13,020
+31% +$1.3M 0.23% 72
2018
Q2
$3.62M Sell
42,400
-4,083
-9% -$335K 0.14% 118
2018
Q1
$3.6M Sell
46,483
-2,670
-5% -$215K 0.14% 113
2017
Q4
$4.15M Sell
49,153
-12,894
-21% -$1.1M 0.16% 109
2017
Q3
$5.31M Buy
62,047
+2,084
+3% +$171K 0.22% 75
2017
Q2
$4.93M Buy
59,963
+859
+1% +$70.1K 0.22% 80
2017
Q1
$4.97M Buy
59,104
+3,626
+7% +$290K 0.22% 70
2016
Q4
$4.08M Sell
55,478
-5,868
-10% -$437K 0.19% 83
2016
Q3
$4.92M Sell
61,346
-835
-1% -$66.8K 0.23% 68
2016
Q2
$4.9M Sell
62,181
-5,967
-9% -$449K 0.24% 64
2016
Q1
$4.91M Sell
68,148
-18,840
-22% -$1.43M 0.25% 60
2015
Q4
$7.33M Sell
86,988
-3,905
-4% -$324K 0.35% 39
2015
Q3
$7.61M Sell
90,893
-26,016
-22% -$2.2M 0.43% 29
2015
Q2
$9.76M Buy
116,909
+979
+0.8% +$74.6K 0.4% 33
2015
Q1
$8.42M Buy
115,930
+5,998
+5% +$427K 0.33% 42
2014
Q4
$7.58M Buy
109,932
+12,090
+12% +$816K 0.31% 47
2014
Q3
$6.34M Buy
97,842
+12,648
+15% +$801K 0.3% 46
2014
Q2
$5.3M Sell
85,194
-3,732
-4% -$223K 0.23% 59
2014
Q1
$5.23M Buy
88,926
+14,741
+20% +$823K 0.24% 51
2013
Q4
$3.78M Buy
74,185
+4,052
+6% +$203K 0.17% 80
2013
Q3
$3.53M Buy
70,133
+1,883
+3% +$98.6K 0.19% 74
2013
Q2
$3.35M Buy
+68,250
New +$3.71M 0.24% 65

Other funds holding LLY

Profund Advisors's LLY Position: Q1 2026 in Review

Profund Advisors reduced its Eli Lilly (LLY) stake by 32% in Q1 2026, selling an estimated $4.56M and leaving 9,591 shares worth $8.82M. The position accounts for 0.32% of the portfolio, ranked #45.

Profund Advisors first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $15.1M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Profund Advisors held 9,591 shares of Eli Lilly worth $8.82M as of Q1 2026.
  • Profund Advisors sold 4,499 Eli Lilly shares in Q1 2026, an estimated $4.56M.
  • Eli Lilly made up 0.32% of Profund Advisors's portfolio in Q1 2026, its #45 holding.
  • Profund Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Profund Advisors's Eli Lilly position peaked at $15.1M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Profund Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.